chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Menstrual disorder
Clinical narrative: Menstrual cycle arrived 2 weeks early. I am always outside the 28 window mark. Anywhere from 30-40 days is my regular.  I've never been early. Cramps are usually minimal for me, no need for medication and only one day of real discomfort. Cramps where instant and I needed a pain killers yesterday and today. Today subsided in the evening.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness on left arm all the way to fingertips, left side of chest, left side of neck, lower left side of face
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope
Clinical narrative: PATIENT BECAME FAINT &  DIZZY WHILE SITTING AND WAITING FOR 15 MINUTES. ED CALLED PARAMEDICS ARRIVED. CHECKED VITALS. PATIENT WAS FEELING BETTER. PARAMEDICS STATED IT WAS OK TO GO HOME BUT CONTINUE TO MONITOR IF CHANGE.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 immunisation, Extra dose administered
Clinical narrative: PATIENT CAME IN LOOKING FOR A 1ST DOSE PFIZER SHOT. REPORTED IT AS FIRST COVID SHOT. UPON BILLING DISCOVERED THAT SHE HAD ALRAEDY RECEIVED A JOHNSON AND JOHNSON BACK IN APRIL
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide, Chest X-ray, Chills, Dyspnoea, Electrocardiogram normal
Clinical narrative: Shortness of breath, Myalgia, Malaise and fatique, chills without fever, not able to exercise the 5 miles daily routine since the vaccine. Short winded with regular day to day housework. No chest pain. fatigue continued for weeks after initial vaccine. Symptoms continued. Arm swollen and red for days after vaccine. No travel. no sick contacts. no wheezing, no cough. no leg swelling or leg pain. no headaches, no change in taste or smell. No GI symptoms, No history of blood clot bleeding disorder. Does have history of colon cancer
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Fibrin D dimer increased, Full blood count, Influenza virus test negative
Clinical narrative: Shortness of breath, Myalgia, Malaise and fatique, chills without fever, not able to exercise the 5 miles daily routine since the vaccine. Short winded with regular day to day housework. No chest pain. fatigue continued for weeks after initial vaccine. Symptoms continued. Arm swollen and red for days after vaccine. No travel. no sick contacts. no wheezing, no cough. no leg swelling or leg pain. no headaches, no change in taste or smell. No GI symptoms, No history of blood clot bleeding disorder. Does have history of colon cancer
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Malaise, Metabolic function test, Myalgia, Peripheral swelling
Clinical narrative: Shortness of breath, Myalgia, Malaise and fatique, chills without fever, not able to exercise the 5 miles daily routine since the vaccine. Short winded with regular day to day housework. No chest pain. fatigue continued for weeks after initial vaccine. Symptoms continued. Arm swollen and red for days after vaccine. No travel. no sick contacts. no wheezing, no cough. no leg swelling or leg pain. no headaches, no change in taste or smell. No GI symptoms, No history of blood clot bleeding disorder. Does have history of colon cancer
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Troponin I, Urine analysis, Ventilation/perfusion scan
Clinical narrative: Shortness of breath, Myalgia, Malaise and fatique, chills without fever, not able to exercise the 5 miles daily routine since the vaccine. Short winded with regular day to day housework. No chest pain. fatigue continued for weeks after initial vaccine. Symptoms continued. Arm swollen and red for days after vaccine. No travel. no sick contacts. no wheezing, no cough. no leg swelling or leg pain. no headaches, no change in taste or smell. No GI symptoms, No history of blood clot bleeding disorder. Does have history of colon cancer
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse effects reported. Patient's age does not match indication of vaccine. Mother was made aware.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product misuse to child, Product administered to patient of inappropriate age
Clinical narrative: Father admitted that he lied about daughter's age in order to get child vaccinated before school starts. Patient is still 11 year old
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Headache
Clinical narrative: fever, cough, nasal congestion, runny nose, sore throat, body aches, chills, decreased taste, decreased smell, headache, shortness of breath with positive COVID PCR on 7/31/21
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Hypogeusia, Hyposmia, Nasal congestion, Oropharyngeal pain, Pain
Clinical narrative: fever, cough, nasal congestion, runny nose, sore throat, body aches, chills, decreased taste, decreased smell, headache, shortness of breath with positive COVID PCR on 7/31/21
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: fever, cough, nasal congestion, runny nose, sore throat, body aches, chills, decreased taste, decreased smell, headache, shortness of breath with positive COVID PCR on 7/31/21
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram, Hemiparesis, Magnetic resonance imaging
Clinical narrative: Stroke, weakness on left side of the body, in rehab now. Too soon to tell if patient will regain use of left side.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blood test, Cauda equina syndrome, Guillain-Barre syndrome, Hypoaesthesia
Clinical narrative: I experienced progressive ascending numbness that began in my hands and feet over the course of several weeks, including oral and saddle paresthesia. I have altered vision and balance during this course and ultimately had 2 doctor visits, two emergency department visits, a neurology visit and multiple tests performed (see item 19). The final diagnosis was a variant of Guillain Barre Syndrome.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging head, Magnetic resonance imaging neck, Metamorphopsia, Paraesthesia oral
Clinical narrative: I experienced progressive ascending numbness that began in my hands and feet over the course of several weeks, including oral and saddle paresthesia. I have altered vision and balance during this course and ultimately had 2 doctor visits, two emergency department visits, a neurology visit and multiple tests performed (see item 19). The final diagnosis was a variant of Guillain Barre Syndrome.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Heart rate decreased, Hypotension, Loss of consciousness
Clinical narrative: Pt passed out after getting the pfizer covid 19 vaccine, the technician got pharmacist right away and she used ammonia to wake the patient up quickly, her mother caught her and she was confused when she woke up, we were about to move her to the floor when she lost control of her bladder and so the father held her legs for her until we could get another chair under her to keep them elevated without getting near the puddle on the floor. After the paramedics arrived she was still dizzy and had low blood pressure and heart rate so the family decided that she would go in with them to get checked out in the hospital.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary incontinence
Clinical narrative: Pt passed out after getting the pfizer covid 19 vaccine, the technician got pharmacist right away and she used ammonia to wake the patient up quickly, her mother caught her and she was confused when she woke up, we were about to move her to the floor when she lost control of her bladder and so the father held her legs for her until we could get another chair under her to keep them elevated without getting near the puddle on the floor. After the paramedics arrived she was still dizzy and had low blood pressure and heart rate so the family decided that she would go in with them to get checked out in the hospital.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac flutter, Chills, Dyspnoea, Fatigue, Hypersensitivity
Clinical narrative: On Friday, July 30 in the evening around 5pm, I began experiencing symptoms of fatigue, chills, and body sensitivity while making dinner and so I sat down and rested. My temperature was 99.7. I took ibuprofen 600mg around 8pm and the symptoms resolved. However the same symptoms returned the next evening on July 31 and I also began experiencing shortness of breath in the morning and fluttering heart. I called my doctor on Sunday August 1 to determine course of action. I reported the fatigue symptoms and she suggested that I may be experiencing a delayed reaction to the 2nd dose of covid vaccine which I had received earlier on July 21st.  A COVID is unlikely because I was self-isolating in my home 14days prior to the start of my symptoms.  This morning on August 3 I woke up again with shortness of breath and fluttering heart which have been ongoing all day. I had difficulty washing my hair because of the shortness of breath,. I feel like I need to work harder to get a single breath. I believe these symptoms were caused by the vaccination .
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: On Friday, July 30 in the evening around 5pm, I began experiencing symptoms of fatigue, chills, and body sensitivity while making dinner and so I sat down and rested. My temperature was 99.7. I took ibuprofen 600mg around 8pm and the symptoms resolved. However the same symptoms returned the next evening on July 31 and I also began experiencing shortness of breath in the morning and fluttering heart. I called my doctor on Sunday August 1 to determine course of action. I reported the fatigue symptoms and she suggested that I may be experiencing a delayed reaction to the 2nd dose of covid vaccine which I had received earlier on July 21st.  A COVID is unlikely because I was self-isolating in my home 14days prior to the start of my symptoms.  This morning on August 3 I woke up again with shortness of breath and fluttering heart which have been ongoing all day. I had difficulty washing my hair because of the shortness of breath,. I feel like I need to work harder to get a single breath. I believe these symptoms were caused by the vaccination .
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Cough, Fatigue
Clinical narrative: Tiredness Weakness Dry cough Chest pain
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 1st dose of COVID vaccine Moderna administered not realizing that Moderna was not yet approved for 12 yr + up  No adverse reaction at this time
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic shock, Paraesthesia, Pruritus
Clinical narrative: 12 episodes of sever itching and tingling in the extremities 07/20/-07/31. I took 50 mg Benadryl at the time of 9 episodes. I took 25 mg Benadryl 2time. On July 30, the reaction started to move to my face and throat so I went to the Hospital ER at 12:38pm where I was treated for 4 hours.   I have not been at the ER for anaphylactic shock since 1998 as I avoid the medications and food to which I am allergic. I have had 3 episodes of the tingling and itching in the extremities  since the ER visit, but i did not go into anaphylactic shock.  The dates and times of reactions are:  07/24. 8:35 pm. Took 50 mg Benadryl. 07/25. 9:35 pm. Took 50 Benadryl 07/26 3:45 am. Took 50 mg Benadryl.          4:07pm. Took 50 mg Benadryl. 07/30 2:25 am. Took 50 mg Benadryl          8:45 Am. Took 50 mg Benadryl.          12:15 pm. Reaction was much more sever and also included a feeling of tingling around my mouth and constriction in my throat. I went to Hospital Emergency Room. I took 50 mg Benadryl in the car at 12:38pm. I was seen 40 minutes later and stayed in the ER until 4:30pm. I was given 1 soda 20 mg at 4 pm and got prescription for 1 daily for 5 days.  08/01.  3am. Had the tingling and itching as before the visit to the ER and took 50 mg Benadryl.            1:15pm. Same reaction . Took 50 mg Benadryl.   Twelve reactions.   As of 5:52 pm , 08/02, and as of this writing, no more reactions since 8/01/21.   I would welcome any telephone follow up as I had trouble:understanding the prompts and want to provide my information appropriately.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Paraesthesia, Paraesthesia oral, Pharyngeal paraesthesia, Pruritus
Clinical narrative: 12 episodes of sever itching and tingling in the extremities 07/20/-07/31. I took 50 mg Benadryl at the time of 9 episodes. I took 25 mg Benadryl 2time. On July 30, the reaction started to move to my face and throat so I went to the Hospital ER at 12:38pm where I was treated for 4 hours.   I have not been at the ER for anaphylactic shock since 1998 as I avoid the medications and food to which I am allergic. I have had 3 episodes of the tingling and itching in the extremities  since the ER visit, but i did not go into anaphylactic shock.  The dates and times of reactions are:  07/24. 8:35 pm. Took 50 mg Benadryl. 07/25. 9:35 pm. Took 50 Benadryl 07/26 3:45 am. Took 50 mg Benadryl.          4:07pm. Took 50 mg Benadryl. 07/30 2:25 am. Took 50 mg Benadryl          8:45 Am. Took 50 mg Benadryl.          12:15 pm. Reaction was much more sever and also included a feeling of tingling around my mouth and constriction in my throat. I went to Hospital Emergency Room. I took 50 mg Benadryl in the car at 12:38pm. I was seen 40 minutes later and stayed in the ER until 4:30pm. I was given 1 soda 20 mg at 4 pm and got prescription for 1 daily for 5 days.  08/01.  3am. Had the tingling and itching as before the visit to the ER and took 50 mg Benadryl.            1:15pm. Same reaction . Took 50 mg Benadryl.   Twelve reactions.   As of 5:52 pm , 08/02, and as of this writing, no more reactions since 8/01/21.   I would welcome any telephone follow up as I had trouble:understanding the prompts and want to provide my information appropriately.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation, Throat tightness, Tryptase
Clinical narrative: 12 episodes of sever itching and tingling in the extremities 07/20/-07/31. I took 50 mg Benadryl at the time of 9 episodes. I took 25 mg Benadryl 2time. On July 30, the reaction started to move to my face and throat so I went to the Hospital ER at 12:38pm where I was treated for 4 hours.   I have not been at the ER for anaphylactic shock since 1998 as I avoid the medications and food to which I am allergic. I have had 3 episodes of the tingling and itching in the extremities  since the ER visit, but i did not go into anaphylactic shock.  The dates and times of reactions are:  07/24. 8:35 pm. Took 50 mg Benadryl. 07/25. 9:35 pm. Took 50 Benadryl 07/26 3:45 am. Took 50 mg Benadryl.          4:07pm. Took 50 mg Benadryl. 07/30 2:25 am. Took 50 mg Benadryl          8:45 Am. Took 50 mg Benadryl.          12:15 pm. Reaction was much more sever and also included a feeling of tingling around my mouth and constriction in my throat. I went to Hospital Emergency Room. I took 50 mg Benadryl in the car at 12:38pm. I was seen 40 minutes later and stayed in the ER until 4:30pm. I was given 1 soda 20 mg at 4 pm and got prescription for 1 daily for 5 days.  08/01.  3am. Had the tingling and itching as before the visit to the ER and took 50 mg Benadryl.            1:15pm. Same reaction . Took 50 mg Benadryl.   Twelve reactions.   As of 5:52 pm , 08/02, and as of this writing, no more reactions since 8/01/21.   I would welcome any telephone follow up as I had trouble:understanding the prompts and want to provide my information appropriately.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 1st dose of Covid Vaccine Moderna administered not realizing that Moderna was not yet approved for 12&^ No adverse reaction at this time
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was given the vaccine at 15 years old, which apparently at that time was below the minimum permitted age. The age has since been reduced to 12 years old. Our corporate office has requested that we submit a report. No adverse reactions were reported, however the vaccines provided on 04/03/2021 and 04/25/2021 are to be reported as given in error.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antinuclear antibody, Blister, Blood creatine phosphokinase normal, Burning sensation, C-reactive protein
Clinical narrative: 1st Dose March 2, 2021: No reaction 2nd Dose March 23, 2021: Severe Skin Disturbance Burning inside my hands, fingers, Face, Neck Unbearable pain from the burning and blisters/forearms Blisters would form from the inside of my body's burning to the outside then pop and bleed. Symmetrical pattern on both sides of my body.  My severe skin Disterbance was symmetrical Rheumatologist Visit: Many appointments and Medical tests to eliminate causes for my burning and blistering rash and reaction after the Covid Pfizer 2nd vaccine Burning and Blistering Pain Unbearable Urgent Care Visit: Buring and Blistering Pain Unbearable Dermatologist Visit: Many appointments and Medical tests to determine the cause of the intense burning and blistering with unbearable pain. after the 2nd Pzizer Covid Shot on March 23, 2021 I broke out on my face first, then Neck then hands and forearms on March 29, 2021. Ears and Ankles started but never as severe as the rest.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Paraesthesia, Porphyrins urine normal, Rash
Clinical narrative: 1st Dose March 2, 2021: No reaction 2nd Dose March 23, 2021: Severe Skin Disturbance Burning inside my hands, fingers, Face, Neck Unbearable pain from the burning and blisters/forearms Blisters would form from the inside of my body's burning to the outside then pop and bleed. Symmetrical pattern on both sides of my body.  My severe skin Disterbance was symmetrical Rheumatologist Visit: Many appointments and Medical tests to eliminate causes for my burning and blistering rash and reaction after the Covid Pfizer 2nd vaccine Burning and Blistering Pain Unbearable Urgent Care Visit: Buring and Blistering Pain Unbearable Dermatologist Visit: Many appointments and Medical tests to determine the cause of the intense burning and blistering with unbearable pain. after the 2nd Pzizer Covid Shot on March 23, 2021 I broke out on my face first, then Neck then hands and forearms on March 29, 2021. Ears and Ankles started but never as severe as the rest.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash vesicular
Clinical narrative: 1st Dose March 2, 2021: No reaction 2nd Dose March 23, 2021: Severe Skin Disturbance Burning inside my hands, fingers, Face, Neck Unbearable pain from the burning and blisters/forearms Blisters would form from the inside of my body's burning to the outside then pop and bleed. Symmetrical pattern on both sides of my body.  My severe skin Disterbance was symmetrical Rheumatologist Visit: Many appointments and Medical tests to eliminate causes for my burning and blistering rash and reaction after the Covid Pfizer 2nd vaccine Burning and Blistering Pain Unbearable Urgent Care Visit: Buring and Blistering Pain Unbearable Dermatologist Visit: Many appointments and Medical tests to determine the cause of the intense burning and blistering with unbearable pain. after the 2nd Pzizer Covid Shot on March 23, 2021 I broke out on my face first, then Neck then hands and forearms on March 29, 2021. Ears and Ankles started but never as severe as the rest.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: No adverse event
Clinical narrative: VIS GIVEN TO MOM. VERIFIED BY ANOTHER . NO REACTION .
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Nausea, Palpitations
Clinical narrative: Pt c/o "heart racing, some mild nausea and mild headache." Pt stated "I think I got myself worked up and over thought it after vaccine was given. I know how I do with medicines and reactions and got upset." Benadryl Elixir given Pt under care of allergist, no Rx for allergies, just uses OT Benadryl when symptoms start
Age: 5.0
Sex: M
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: s/s COVID
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Papule, Rash
Clinical narrative: (+) small flesh colored papules on his abdomen and back noted 2.5 days after his 1 year old vaccines. At the clinic on 7/29/2021 325pm (+) small red papules on the chest, abdomen and thighs. No medications given. In other ways advised rashes will spontaneously.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Exposure during pregnancy, Injection site pain, Nausea, Presyncope
Clinical narrative: exhaustion; Injection site soreness; extreme hot flashes; nausea; maternal exposure during pregnancy; This is a spontaneous report from a contactable consumer or other non hcp. This consumer or other non hcp reported information for both mother and fetus/baby.   A 29-years-old pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number : Not known), via an unspecified route of administration, administered in Arm Left on 26Feb2021 11:30 (at the age of 29-years-old)  as dose 1, single for COVID-19 immunisation. Medical history were none. The patient's concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 26Feb2021 11:30 , the patient experienced maternal exposure during pregnancy. The patient's last menstrual date was on 20Sep2021. On 26Feb2021 12:30, patient experienced exhaustion, injection site soreness, extreme hot flashes, nausea. The mother reported she became pregnant while taking BNT162B2. The mother was 25 Weeks pregnant at the onset of the event. The mother was due to deliver on 09Jun2021. Since the vaccination, the patient had not been tested for COVID-19.  No therapeutic measures were taken as a result of events. The outcome of the events were recovered on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hot flush, Maternal exposure during pregnancy, Nausea, Vaccination site pain
Clinical narrative: exhaustion; Injection site soreness; extreme hot flashes; nausea; maternal exposure during pregnancy; This is a spontaneous report from a contactable consumer or other non hcp. This consumer or other non hcp reported information for both mother and fetus/baby.   A 29-years-old pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number : Not known), via an unspecified route of administration, administered in Arm Left on 26Feb2021 11:30 (at the age of 29-years-old)  as dose 1, single for COVID-19 immunisation. Medical history were none. The patient's concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 26Feb2021 11:30 , the patient experienced maternal exposure during pregnancy. The patient's last menstrual date was on 20Sep2021. On 26Feb2021 12:30, patient experienced exhaustion, injection site soreness, extreme hot flashes, nausea. The mother reported she became pregnant while taking BNT162B2. The mother was 25 Weeks pregnant at the onset of the event. The mother was due to deliver on 09Jun2021. Since the vaccination, the patient had not been tested for COVID-19.  No therapeutic measures were taken as a result of events. The outcome of the events were recovered on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Palpitations, Toxic nodular goitre
Clinical narrative: heart suddenly started racing; felt dizzy and very light headed; This is a spontaneous report from a contactable consumer, the patient. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: ENG911), via an unspecified route of administration, administered in Left arm, on 09Mar2021 at 13:00 as dose 1, single for covid-19 immunization. Medical history included Hyperthyroidism due to toxic nodule from an unknown date and unknown if ongoing. Concomitant medications included sertraline hydrochloride (ZOLOFT, 100 mg, daily) and thiamazole (TAPAZOLE, 0.5 DF, 2x/week / 1/2 tab Tapazole 2xweek), both taken for an unspecified indication, start and stop dates were not reported. The patient previously took epinephrine and had the same reaction (Known allergies: have the same reaction to epinephrine). The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with covid prior vaccination and no covid test was dose post vaccination. On 09Mar2021 at 01:00 PM, the patient had within one minute of injection, her heart suddenly started racing and she felt dizzy and very lightheaded. No corrective treatment was received for the events. The outcome of the events was Recovered with lasting effects on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Heart rate, Palpitations
Clinical narrative: heart suddenly started racing; felt dizzy and very light headed; This is a spontaneous report from a contactable consumer, the patient. A 49-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: ENG911), via an unspecified route of administration, administered in Left arm, on 09Mar2021 at 13:00 as dose 1, single for covid-19 immunization. Medical history included Hyperthyroidism due to toxic nodule from an unknown date and unknown if ongoing. Concomitant medications included sertraline hydrochloride (ZOLOFT, 100 mg, daily) and thiamazole (TAPAZOLE, 0.5 DF, 2x/week / 1/2 tab Tapazole 2xweek), both taken for an unspecified indication, start and stop dates were not reported. The patient previously took epinephrine and had the same reaction (Known allergies: have the same reaction to epinephrine). The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with covid prior vaccination and no covid test was dose post vaccination. On 09Mar2021 at 01:00 PM, the patient had within one minute of injection, her heart suddenly started racing and she felt dizzy and very lightheaded. No corrective treatment was received for the events. The outcome of the events was Recovered with lasting effects on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Heart rate increased, Palpitations
Clinical narrative: heart racing and beating very hard; This is a spontaneous report from a contactable consumer (patient).   A 57-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6201), via an unspecified route of administration in the left arm on 06Mar2021 at 09:45 (at the age of 57-years-old) as a dose 2, single for COVID-19 immunization. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9261), via an unspecified route of administration in the left arm on 29Jan2021 at 09:15 (at the age of 57-years-old) as a dose 1, single for COVID-19 immunization. The most recent COVID-19 vaccine was administered in the public health clinic facility. Medical history included High blood pressure and rapid heart rate and meds control it. There were no known allergies. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced heart racing and beating very hard on 07Mar2021 13:00 for about 45 min. The patient did not receive any treatment. The clinical outcome for the event was recovered on an unspecified date 2021.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: heart racing and beating very hard; This is a spontaneous report from a contactable consumer (patient).   A 57-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6201), via an unspecified route of administration in the left arm on 06Mar2021 at 09:45 (at the age of 57-years-old) as a dose 2, single for COVID-19 immunization. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9261), via an unspecified route of administration in the left arm on 29Jan2021 at 09:15 (at the age of 57-years-old) as a dose 1, single for COVID-19 immunization. The most recent COVID-19 vaccine was administered in the public health clinic facility. Medical history included High blood pressure and rapid heart rate and meds control it. There were no known allergies. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced heart racing and beating very hard on 07Mar2021 13:00 for about 45 min. The patient did not receive any treatment. The clinical outcome for the event was recovered on an unspecified date 2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pain, Palpitations
Clinical narrative: heart palpitations; sore arm; body ache; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 62-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included Hypertension, Hypothyroidism, arthritis. The patient's concomitant medications were not reported. The patient reported that she received the 1st dose "06Mar2021 (as reported) and 3 days later she had heart palpitations and she never had that before and it lasted for 3 days on and off, one days it lasted for a few hours. It's gone now, just had the occasional flip flop of her heart. She also had a sore arm and body ache". She spoke to her doctor and he said to call Pfizer. The patient got her 1st dose on 05Mar2021 and on 08Mar2021 she started having heart palpitations and read that it is a side effect, but she wanted to know if it's safe for her take her 2nd dose. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Palpitations
Clinical narrative: heart palpitations; sore arm; body ache; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 62-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included Hypertension, Hypothyroidism, arthritis. The patient's concomitant medications were not reported. The patient reported that she received the 1st dose "06Mar2021 (as reported) and 3 days later she had heart palpitations and she never had that before and it lasted for 3 days on and off, one days it lasted for a few hours. It's gone now, just had the occasional flip flop of her heart. She also had a sore arm and body ache". She spoke to her doctor and he said to call Pfizer. The patient got her 1st dose on 05Mar2021 and on 08Mar2021 she started having heart palpitations and read that it is a side effect, but she wanted to know if it's safe for her take her 2nd dose. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Back pain, Bone pain, Gait disturbance, Mobility decreased
Clinical narrative: Patient received the first Moderna vaccine on January 28th, 2021. Three days later, patient developed diffuse muscle ache and joint pain with significant stiffness limiting mobility (Knees, neck, shoulders, wrists, elbows, entire spine, and hip).  Despite these symptoms, patient did receive the second vaccine on 2/25/21. After that, the patient developed a fever and was seen in ED. Her symptoms continued to worsen. She continued to have persistent symptoms.   Patient was seen in the ER multiple times, and on the last ER visit, patient had MRI of her spine w/ and w/o contrast that showed:  1. Diffuse increased enhancement within the interspinous ligaments and medial posterior paraspinous musculature adjacent to the spinous processes from C1-C2 to the level of T2-T3, lower thoracic spine extending to the L5-S1 with associated reactive dorsal epidural venous plexus enhancement. Overall findings can be accentuated by fat-saturated postcontrast images however possibility of inflammatory/infectious myositis cannot be completely excluded. Correlation with clinical presentation and laboratory analysis is recommended. Short-term follow-up MRI of the spine with and without contrast should also be considered. 2. No definite spinal cord signal abnormality or postcontrast spinal cord enhancement. 3. Degenerative spondylitic changes in the lower cervical and lower lumbar spine as detail above.   Patient has received an EMG in March 2021 and was normal for motor and sensory nerves. Patient's EMG was not concerning for a myositis.    Other than that, patient has had a positive TPA and RPR screening; it's confirmed that she has had received treatment for syphilis. Her inflammatory markers are high with ESR at 69 and CRP > 13 two times.  She was referred to rheumatology clinic for the above findings.   At her initial visit in March 2021, our concern was for polymyalgia rheumatica after Moderna vaccination. We started 20 mg of prednisone daily. In April 2021, she had mild improvement in neck and back stiffness to where she was now able to walk but with a walker and her daily activities still impaired. We increased her prednisone to 60 mg daily. At this time, the patient also complained of L eye vision loss and L ear hearing loss. We referred to her to ophthalmology and audiology but she states she missed her appointments due to transportation.    At visit 5/24, she was doing a lot better and inflammatory markers had normalized. Plan was to taper prednisone to 50 mg daily for 2 weeks and 40 mg daily for 2 weeks. At visit on 6/21 she was doing better but still reporting some neck and pelvic girdle stiffness so prednisone tapered to 30 mg for 1 month then 20 mg daily and methotrexate 15 mg PO weekly added.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Patient received the first Moderna vaccine on January 28th, 2021. Three days later, patient developed diffuse muscle ache and joint pain with significant stiffness limiting mobility (Knees, neck, shoulders, wrists, elbows, entire spine, and hip).  Despite these symptoms, patient did receive the second vaccine on 2/25/21. After that, the patient developed a fever and was seen in ED. Her symptoms continued to worsen. She continued to have persistent symptoms.   Patient was seen in the ER multiple times, and on the last ER visit, patient had MRI of her spine w/ and w/o contrast that showed:  1. Diffuse increased enhancement within the interspinous ligaments and medial posterior paraspinous musculature adjacent to the spinous processes from C1-C2 to the level of T2-T3, lower thoracic spine extending to the L5-S1 with associated reactive dorsal epidural venous plexus enhancement. Overall findings can be accentuated by fat-saturated postcontrast images however possibility of inflammatory/infectious myositis cannot be completely excluded. Correlation with clinical presentation and laboratory analysis is recommended. Short-term follow-up MRI of the spine with and without contrast should also be considered. 2. No definite spinal cord signal abnormality or postcontrast spinal cord enhancement. 3. Degenerative spondylitic changes in the lower cervical and lower lumbar spine as detail above.   Patient has received an EMG in March 2021 and was normal for motor and sensory nerves. Patient's EMG was not concerning for a myositis.    Other than that, patient has had a positive TPA and RPR screening; it's confirmed that she has had received treatment for syphilis. Her inflammatory markers are high with ESR at 69 and CRP > 13 two times.  She was referred to rheumatology clinic for the above findings.   At her initial visit in March 2021, our concern was for polymyalgia rheumatica after Moderna vaccination. We started 20 mg of prednisone daily. In April 2021, she had mild improvement in neck and back stiffness to where she was now able to walk but with a walker and her daily activities still impaired. We increased her prednisone to 60 mg daily. At this time, the patient also complained of L eye vision loss and L ear hearing loss. We referred to her to ophthalmology and audiology but she states she missed her appointments due to transportation.    At visit 5/24, she was doing a lot better and inflammatory markers had normalized. Plan was to taper prednisone to 50 mg daily for 2 weeks and 40 mg daily for 2 weeks. At visit on 6/21 she was doing better but still reporting some neck and pelvic girdle stiffness so prednisone tapered to 30 mg for 1 month then 20 mg daily and methotrexate 15 mg PO weekly added.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anti-cyclic citrullinated peptide antibody positive, Antinuclear antibody, Antinuclear antibody negative, Antinuclear antibody positive, Arthralgia
Clinical narrative: Patient received the first Moderna vaccine on January 28th, 2021. Three days later, patient developed diffuse muscle ache and joint pain with significant stiffness limiting mobility (Knees, neck, shoulders, wrists, elbows, entire spine, and hip).  Despite these symptoms, patient did receive the second vaccine on 2/25/21. After that, the patient developed a fever and was seen in ED. Her symptoms continued to worsen. She continued to have persistent symptoms.   Patient was seen in the ER multiple times, and on the last ER visit, patient had MRI of her spine w/ and w/o contrast that showed:  1. Diffuse increased enhancement within the interspinous ligaments and medial posterior paraspinous musculature adjacent to the spinous processes from C1-C2 to the level of T2-T3, lower thoracic spine extending to the L5-S1 with associated reactive dorsal epidural venous plexus enhancement. Overall findings can be accentuated by fat-saturated postcontrast images however possibility of inflammatory/infectious myositis cannot be completely excluded. Correlation with clinical presentation and laboratory analysis is recommended. Short-term follow-up MRI of the spine with and without contrast should also be considered. 2. No definite spinal cord signal abnormality or postcontrast spinal cord enhancement. 3. Degenerative spondylitic changes in the lower cervical and lower lumbar spine as detail above.   Patient has received an EMG in March 2021 and was normal for motor and sensory nerves. Patient's EMG was not concerning for a myositis.    Other than that, patient has had a positive TPA and RPR screening; it's confirmed that she has had received treatment for syphilis. Her inflammatory markers are high with ESR at 69 and CRP > 13 two times.  She was referred to rheumatology clinic for the above findings.   At her initial visit in March 2021, our concern was for polymyalgia rheumatica after Moderna vaccination. We started 20 mg of prednisone daily. In April 2021, she had mild improvement in neck and back stiffness to where she was now able to walk but with a walker and her daily activities still impaired. We increased her prednisone to 60 mg daily. At this time, the patient also complained of L eye vision loss and L ear hearing loss. We referred to her to ophthalmology and audiology but she states she missed her appointments due to transportation.    At visit 5/24, she was doing a lot better and inflammatory markers had normalized. Plan was to taper prednisone to 50 mg daily for 2 weeks and 40 mg daily for 2 weeks. At visit on 6/21 she was doing better but still reporting some neck and pelvic girdle stiffness so prednisone tapered to 30 mg for 1 month then 20 mg daily and methotrexate 15 mg PO weekly added.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blindness unilateral, Blood creatine phosphokinase normal, C-reactive protein increased, Complement factor C3, Complement factor C4
Clinical narrative: Patient received the first Moderna vaccine on January 28th, 2021. Three days later, patient developed diffuse muscle ache and joint pain with significant stiffness limiting mobility (Knees, neck, shoulders, wrists, elbows, entire spine, and hip).  Despite these symptoms, patient did receive the second vaccine on 2/25/21. After that, the patient developed a fever and was seen in ED. Her symptoms continued to worsen. She continued to have persistent symptoms.   Patient was seen in the ER multiple times, and on the last ER visit, patient had MRI of her spine w/ and w/o contrast that showed:  1. Diffuse increased enhancement within the interspinous ligaments and medial posterior paraspinous musculature adjacent to the spinous processes from C1-C2 to the level of T2-T3, lower thoracic spine extending to the L5-S1 with associated reactive dorsal epidural venous plexus enhancement. Overall findings can be accentuated by fat-saturated postcontrast images however possibility of inflammatory/infectious myositis cannot be completely excluded. Correlation with clinical presentation and laboratory analysis is recommended. Short-term follow-up MRI of the spine with and without contrast should also be considered. 2. No definite spinal cord signal abnormality or postcontrast spinal cord enhancement. 3. Degenerative spondylitic changes in the lower cervical and lower lumbar spine as detail above.   Patient has received an EMG in March 2021 and was normal for motor and sensory nerves. Patient's EMG was not concerning for a myositis.    Other than that, patient has had a positive TPA and RPR screening; it's confirmed that she has had received treatment for syphilis. Her inflammatory markers are high with ESR at 69 and CRP > 13 two times.  She was referred to rheumatology clinic for the above findings.   At her initial visit in March 2021, our concern was for polymyalgia rheumatica after Moderna vaccination. We started 20 mg of prednisone daily. In April 2021, she had mild improvement in neck and back stiffness to where she was now able to walk but with a walker and her daily activities still impaired. We increased her prednisone to 60 mg daily. At this time, the patient also complained of L eye vision loss and L ear hearing loss. We referred to her to ophthalmology and audiology but she states she missed her appointments due to transportation.    At visit 5/24, she was doing a lot better and inflammatory markers had normalized. Plan was to taper prednisone to 50 mg daily for 2 weeks and 40 mg daily for 2 weeks. At visit on 6/21 she was doing better but still reporting some neck and pelvic girdle stiffness so prednisone tapered to 30 mg for 1 month then 20 mg daily and methotrexate 15 mg PO weekly added.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Deafness unilateral, Double stranded DNA antibody, Electromyogram normal, Gait disturbance, Inflammatory marker increased
Clinical narrative: Patient received the first Moderna vaccine on January 28th, 2021. Three days later, patient developed diffuse muscle ache and joint pain with significant stiffness limiting mobility (Knees, neck, shoulders, wrists, elbows, entire spine, and hip).  Despite these symptoms, patient did receive the second vaccine on 2/25/21. After that, the patient developed a fever and was seen in ED. Her symptoms continued to worsen. She continued to have persistent symptoms.   Patient was seen in the ER multiple times, and on the last ER visit, patient had MRI of her spine w/ and w/o contrast that showed:  1. Diffuse increased enhancement within the interspinous ligaments and medial posterior paraspinous musculature adjacent to the spinous processes from C1-C2 to the level of T2-T3, lower thoracic spine extending to the L5-S1 with associated reactive dorsal epidural venous plexus enhancement. Overall findings can be accentuated by fat-saturated postcontrast images however possibility of inflammatory/infectious myositis cannot be completely excluded. Correlation with clinical presentation and laboratory analysis is recommended. Short-term follow-up MRI of the spine with and without contrast should also be considered. 2. No definite spinal cord signal abnormality or postcontrast spinal cord enhancement. 3. Degenerative spondylitic changes in the lower cervical and lower lumbar spine as detail above.   Patient has received an EMG in March 2021 and was normal for motor and sensory nerves. Patient's EMG was not concerning for a myositis.    Other than that, patient has had a positive TPA and RPR screening; it's confirmed that she has had received treatment for syphilis. Her inflammatory markers are high with ESR at 69 and CRP > 13 two times.  She was referred to rheumatology clinic for the above findings.   At her initial visit in March 2021, our concern was for polymyalgia rheumatica after Moderna vaccination. We started 20 mg of prednisone daily. In April 2021, she had mild improvement in neck and back stiffness to where she was now able to walk but with a walker and her daily activities still impaired. We increased her prednisone to 60 mg daily. At this time, the patient also complained of L eye vision loss and L ear hearing loss. We referred to her to ophthalmology and audiology but she states she missed her appointments due to transportation.    At visit 5/24, she was doing a lot better and inflammatory markers had normalized. Plan was to taper prednisone to 50 mg daily for 2 weeks and 40 mg daily for 2 weeks. At visit on 6/21 she was doing better but still reporting some neck and pelvic girdle stiffness so prednisone tapered to 30 mg for 1 month then 20 mg daily and methotrexate 15 mg PO weekly added.